rs3749383
Variant summary
Our verdict is Benign. Variant got -19 ACMG points: 1P and 20B. PP2BP4_StrongBP6_Very_StrongBS1BS2
The NM_001378452.1(ITPR1):āc.4288A>Gā(p.Ile1430Val) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00121 in 1,610,434 control chromosomes in the GnomAD database, including 50 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ā ).
Frequency
Consequence
NM_001378452.1 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -19 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ITPR1 | NM_001378452.1 | c.4288A>G | p.Ile1430Val | missense_variant | 34/62 | ENST00000649015.2 | NP_001365381.1 | |
ITPR1 | NM_001168272.2 | c.4243A>G | p.Ile1415Val | missense_variant | 33/61 | NP_001161744.1 | ||
ITPR1 | NM_001099952.4 | c.4261A>G | p.Ile1421Val | missense_variant | 34/59 | NP_001093422.2 | ||
ITPR1 | NM_002222.7 | c.4216A>G | p.Ile1406Val | missense_variant | 33/58 | NP_002213.5 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ITPR1 | ENST00000649015.2 | c.4288A>G | p.Ile1430Val | missense_variant | 34/62 | NM_001378452.1 | ENSP00000497605 |
Frequencies
GnomAD3 genomes AF: 0.00137 AC: 209AN: 152182Hom.: 6 Cov.: 31
GnomAD3 exomes AF: 0.00287 AC: 699AN: 243204Hom.: 14 AF XY: 0.00276 AC XY: 364AN XY: 131736
GnomAD4 exome AF: 0.00119 AC: 1741AN: 1458134Hom.: 44 Cov.: 32 AF XY: 0.00116 AC XY: 844AN XY: 724910
GnomAD4 genome AF: 0.00137 AC: 209AN: 152300Hom.: 6 Cov.: 31 AF XY: 0.00160 AC XY: 119AN XY: 74474
ClinVar
Submissions by phenotype
not provided Benign:2
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Oct 22, 2020 | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 30, 2024 | - - |
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Athena Diagnostics | Oct 15, 2020 | - - |
Gillespie syndrome;C1847725:Spinocerebellar ataxia type 15/16;C1861732:Spinocerebellar ataxia type 29 Benign:1
Benign, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Aug 23, 2021 | - - |
Autosomal dominant cerebellar ataxia Benign:1
Benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jan 12, 2018 | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at